{
  "zip": "75013",
  "sector": "Healthcare",
  "fullTimeEmployees": 253,
  "longBusinessSummary": "Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia (ALL); ALLO-501 to treat relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma; UCART123 for the treatment of acute myeloid leukemia (AML); and UCART22 to treat B-cell acute lymphoblastic leukemia. It is also developing UCARTCS1 and ALLO-715 for the treatment of multiple myeloma. In addition, the company produces high oleic soybean oil, other soybean products, and fiber wheat. It has strategic alliances with Allogene Therapeutics, Inc.; Les Laboratoires Servier; The University of Texas M.D. Anderson Cancer Center; and Iovance Biotherapeutics. The company was founded in 1999 and is headquartered in Paris, France.",
  "city": "Paris",
  "phone": "33 1 81 69 16 00",
  "country": "France",
  "companyOfficers": [],
  "website": "http://www.cellectis.com",
  "maxAge": 1,
  "address1": "8, rue de la Croix Jarry",
  "industry": "Biotechnology",
  "previousClose": 30.07,
  "regularMarketOpen": 30.07,
  "twoHundredDayAverage": 20.619978,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 30.07,
  "navPrice": null,
  "averageDailyVolume10Day": 25,
  "totalAssets": null,
  "regularMarketPreviousClose": 30.07,
  "fiftyDayAverage": 29.122637,
  "trailingAnnualDividendRate": null,
  "open": 30.07,
  "averageVolume10days": 25,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 2.26813,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 30.07,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 100,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 1268181248,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 203,
  "priceToSalesTrailing12Months": 17.397608,
  "dayLow": 30.07,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 100,
  "fiftyTwoWeekHigh": 32.219,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 14.6,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 30.07,
  "exchange": "PNK",
  "shortName": "CELLECTIS",
  "longName": "Cellectis S.A.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CMVLF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_1216695",
  "uuid": "ef3aaf41-c96f-3341-a3bc-82722e707a80",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 15.136,
  "beta3Year": null,
  "profitMargins": -1.08367,
  "enterpriseToEbitda": -12.757,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 42486100,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 6.834,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.27875,
  "netIncomeToCommon": -78993000,
  "trailingEps": -1.87,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 4.4000583,
  "heldPercentInsiders": 0.16763,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 26322284,
  "enterpriseValue": 1103304064,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 30.07,
  "logo_url": "https://logo.clearbit.com/cellectis.com"
}